Abstract
Considerable evidence indicates that conditioned gaping in rats reflects nausea in this species that does not vomit. A series of experiments evaluated the potential of psychoactive cannabinoid agonists, Δ-9-THC and HU-210, and non-psychoactive cannabinoids, Cannabidiol (CBD) and its dimethylheptyl homolog (CBD-dmh), to interfere with the establishment and the expression of conditioned gaping in rats. All agents attenuated both the establishment and the expression of conditioned gaping. Furthermore, the CB1 antagonist, SR-141716, reversed the suppressive effect of HU-210 on conditioned gaping. Finally, SR-141716 potentiated lithium-induced conditioned gaping, suggesting that the endogenous cannabinoid system plays a role in the control of nausea.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berridge, K.C., Grill, H.J. & Norgren, R. (1981). Relation of consummatory responses and preabsorptive insulin release to palatability and learned taste aversions.Journal of Comparative and Physiological Psychology, 95, 363–82.
Blackshaw, L.A. & Grundy, D. (1993). Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret.Journal of the Autonomic Nervous System, 45, 41–50.
Cordick, N., Parker, L.A. & Ossenkopp, K.P. (1999). Rotation-induced conditioned rejection in the taste reactivity test.NeuroReport, 10, 1157–1159.
Darmani, N.A. (2001a). Delta-9-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR-41716A.Neuropsychopharmacology, 24, 198–203.
Darmani, N.A. (2001b). Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew.Pharmacology Biochemistry and Behavior, 69, 239–249.
Darmani, N.A. (2001c). The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55,212-2.European Journal of Pharmacology, 430, 49–58.
Darmani, N.A. (2002). The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannabinoids.Journal of Pharmacology and Experimental Therapeutics, 300, 34–42.
Davis, C.J., Harding, R.K., Leslie, R.A. & Andrews, P.L.R. (1986). The organisation of vomiting as a protective reflex. In: Davis, C.J., Lake-Bakaar, G.V., Grahame-Smith, D.G. (Eds.),Nausea and vomiting: mechanisms and treatment (pp. 65–75). Berlin: Springer-Verlag.
Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor.Science, 258, 1946–1949.
Feigenbaum, J.J., Richmond, S.A., Weissman, Y. & Mechoulam, R. (1989). Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid.European Journal of Pharmacology, 4, 159–165.
Ferrari, F., Ottani, A. & Giuliani, D. (1999). Cannabimimetic acitivity in rats and pigeons of HU-210, a potent antiemetic drug.Pharmacology, Biochemistry and Behavior, 62, 75–80.
Garcia, J. (1989). Food for Tolman: Cognition and cathexis in concert. In T. Archer & L-G. Nilsson (Eds.)Aversion, Avoidance and Anxiety (pp. 45–85). Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.
Grill, H.C. & Norgren, R. (1978). The taste reactivity test. I: Mimetic responses to gustatory stimuli in neurologically normal rats.Brain Research, 143, 263–79.
Hampson, A.J., Grimaldi, M., Axelrod, J. (1998). Cannabidiol and delta-9-tetrahydrocannabinol are neuroprotective antioxidants.Proceedings of the National Academy of Science, USA, 95, 8268–8273.
Hanus, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D.E., Kustanovick, I., & Mechoulam, R. (2001). 2-Arachidonoyl glycerol ether, endogenous agonist of the cannabinoid CB1 receptor.Proceedings of the National Academy of Science, USA, 98, 3662–3665.
Jin, K.L., Mao, X.O., Goldsmith, P.C. & Greenberg, D.A. (2000). CB1 cannabinoid receptor induction in experimental stroke.Annals of Neurology, 48, 257–261.
Konorski, J. (1967).Integrative activity of the brain: An interdisciplinary approach. University of Chicago Press: Chicago.
Limebeer, C.L. & Parker, L.A. (1999). Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned disgust reactions produced by cyclophoshamide: A rat model of nausea.NeuroReport, 10, 3769–3772.
Limebeer, C.L. & Parker, L.A. (2000). Ondansetron interferes with the establishment and the expression of conditioned disgust reactions: A rat model of nausea.Journal of Experimental Psychology: Animal Behavior Processes, 26, 371–384.
Lowe, S. (1946). Studies on the pharmacology and acute toxicity of compounds with marihuana activity.Journal of Pharmacology and Experimental Therapeutics, 88, 154–161.
Mallet, P.E. & Beninger, R.J. (1998). D-9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand, anandamide, produces conditioned place avoidance.Life Sciences, 62, 2431–2439.
McCarthy, L.E. & Borison, H.L. (1984). Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats.Cancer Treatment Reports, 68, 401–404.
McDonald, R.V., Parker, L.A. and Siegel, S. (1997). Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine.Pharmacology, Biochemistry and Behavior, 58, 1–6.
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Marg, J., & Vogel, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.Biochemical Pharmacology, 50, 83–90.
Ossenkopp, K-P, Parker, L.A., Limebeer, C.L., Burton, P. and Cross-Mellor, S.K. (in press). Vestibular lesions selectively abolish rotation-induced, but not lithium-induced, conditioned taste aversions (oral rejection responses) in rats.Behavioral Neuroscience.
Parker, L.A. (1982). Nonconsummatory and consummatory behavioral CRs elicited by lithium- and amphetamine-paired flavors.Learning and Motivation, 13, 281–303.
Parker, L.A. (1991). Taste reactivity responses elicited by reinforcing drugs: A dose-response analysis.Behavioral Neuroscience, 105, 955–964.
Parker, L.A. (1995). Rewarding drugs produce taste avoidance, but not taste aversion.Neuroscience and Biobehavioral Reviews, 19, 143–51.
Parker, L.A. (1998). Emetic drugs produce conditioned rejection reactions in the taste reactivity test.Journal of Psychophysiology, 12, 3–13.
Parker, L.A. (2003). Taste avoidance and taste aversion: Evidence for two independent processes.Learning and Behavior.
Parker, L.A. & Brosseau, L. (1990). Apomorphine-induced flavor-drug associations: A dose-response analysis by the taste reactivity test and the conditioned taste avoidance test.Pharmacology, Biochemistry and Behavior, 35, 583–87.
Parker, L.A. & Gillies, T. (1995). THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.Behavioral Neuroscience, 109, 71–78.
Parker, L.A. & Kemp, S.W.P. (2001). Tetrahydrocannabinol (THC) interferes with conditioned retching inSuncus murinus: An animal model of anticipatory nausea and vomiting (ANV).NeuroReport, 12, 749–751.
Parker, L.A. & McLeod, K.B. (1991). Chin rub CRs may reflect conditioned sickness elicited by a lithiumpaired sucrose solution.Pharmacology, Biochemistry and Behavior, 40, 983–86.
Parker, L.A., Mechoulam, R. & Schlievert, C (2002). Cannabidiol, a non-psychoactive component of cannabis and its dimethylheptyl homolg suppress nausea in an experimental model with rats.NeuroReport, 13, 567–570.
Parker, L.A., Mechoulam, R., Schlievert, C., Abbott, L., Fudge, M.L. & Burton, P. (2003). Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.Psychopharmacology.
Parker, L.A., Kwaitkowska, M., Burton, P. & Mechoulam, R. (in press). Effect of cannabinoids on lithiuminduced vomiting in theSuncus murinus (house musk shrew).Psychopharmacology.
Pelchat, M.L., Grill, H.J., Rozin, P. & Jacobs, J. (1983). Quality of acquired responses to tastes byRattus norvegicus depends on type of associated discomfort.Journal of Comparative Psychology, 97, 140–53.
Rudd, J.A., Ngan, M.P. & Wai, M.K. (1998). 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin.European Journal of Pharmacology, 352, 143–149.
Sallen, S.E., Zinberg, N.E. & Frei, III E. (1975). Antiemetic effect of delt-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.New England Journal of Medicine, 293, 795–98.
Schmid, P.C., Krebsbach, R.J., Perry, S.R., Dettmer, T.M., Masson, J.L., & Schmid, H.H. (1995). Occurrence and postmortem, generation of anandamide and other long-chain N-acylethanolamines in mammalian brain.FEBS Letters, 375, 117–120.
Shen, M., Piser T.M., Seybold, V.S. & Thayer, S.A. (1996). Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.Journal of Neuroscience, 16, 4322–4334.
Shen, M. & Thayer, S.A. (1998). Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.Molecular Pharmacology, 54, 459–462.
Simoneau, II, Hamza, M.S., Mata, H.P., Siegel, E.M., Vanderah, T.W., Porreca, F., Makryannis, A. & Malan, P. (2001). The cannabinoid agonist WIN 55,212-2 suppresses opioid-induced emesis in ferrets.Anesthesiology, 9, 882–886.
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. & Waku, K. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.Biochem. Biophys. Res. Commun, 215, 89–97.
Travers, J.B. & Norgren, J.B. (1986). Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat.Behavioral Neuroscience, 100, 544–555.
Van Sickle, M.D., Oland, L.D., Ho, W., Hillard, C.J., Mackie, K., Davison, J.S. & Sharkey, K.A. (2001). Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret.Gastroenterology, 121, 767–74.
Zalaquett, C., Parker, L.A. (1989). Further evidence that CTAs produced by lithium and amphetamine are qualitatively different.Learning and Motivation, 20, 413–427.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parker, L.A., Mechoulam, R. Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats. Integrative Physiological & Behavioral Science 38, 133–145 (2003). https://doi.org/10.1007/BF02688831
Issue Date:
DOI: https://doi.org/10.1007/BF02688831